International Psoriasis Council

ICYMI: A new regional collaboration has been announced to improve care for #psoriasis and psoriatic arthritis across Latin America, bringing together IPC, @PsoriasisIFPA, PANLAR, SOLAPSO, and COLAPPIEL. Read the full announcement: psoriasiscouncil.org/ipc-news/inter…

🔁 IPC's latest summary slide provides a practical, clinic-ready framework for assessing disease severity and guiding treatment escalation. Designed as a quick reference, it helps clinicians apply IPC's classification to inform therapy decisions. Download: psoriasiscouncil.org/wp-content/upl…

🔁 Dr. Mari Løset and Dr. Maxwell Sauder join IPC's global network, bringing expertise in translational research, data science, and oncodermatology. Their work strengthens IPC's data-driven, evidence-based approach and expands its presence to Norway. psoriasiscouncil.org/ipc-news/ipc-w…

At the IPC Think Tank, 2025 Fellows were welcomed as #IPCJrCouncilors, marking the completion of their fellowship. Congrats to Malin Assarsson, Nicholas Brownstone, Dina ElDisouki, Jennifer Ngo, Ravi Ramessur, Doriane Sabushimike, & Ralph da Rosa: psoriasiscouncil.org/ipc-news/2025-…

Thank you to everyone who joined the IPC, SOLAPSO, & SOARPSO Educational Partnership Symposium at #RADLA2026! Thanks to our co-chairs, faculty, & partner orgs for bringing together important regional perspectives and discussions relevant to clinical practice across Latin America.

ICYMI: #IPCCouncilor Matias Maskin reviews findings from BADBIR, discussing the impact of first-line biologics on long-term outcomes, faster clearance, and reduced comorbidity risk, and what delayed access may cost patients. psoriasiscouncil.org/commentaries/f… #Psoriasis #Biologics

🔁#AAD2026 delivered late-breaking research, emerging therapies, & new clinical insights. Explore IPC's coverage, including the IEC & IPC Joint Symposium & key psoriasis sessions, summarized by #IPCJrCouncilors Maria-Angeliki Gkini & Josep Riera-Monroig: psoriasiscouncil.org/congress-repor…

In recognition of World Hypertension Day, revisit this video from #IPCCouncilor Dr. Álvaro González-Cantero on psoriasis as an independent risk factor for cardiovascular disease. Watch the full video: psoriasiscouncil.org/resources/the-… #Psoriasis #Hypertension #PsoriasisComorbidities

A new publication in @theJIDJournal, published by the @ILDSDerm, examines how biosimilars may expand global access to psoriasis care. Read the full publication: sciencedirect.com/science/articl… #Psoriasis #Biosimilars #GlobalHealth

📰 ICYMI: The April issue of the IPC Psoriasis Review is now available, featuring: Join 12,000+ professionals staying informed with monthly updates on psoriasis news, research, and education. Read now: mailchi.mp/psoriasiscounc… #PsoriasisEducation #IPCNews #PsoriasisResearch

ICYMI: A new regional collaboration has been announced to improve care for #psoriasis and psoriatic arthritis across Latin America, bringing together IPC, @PsoriasisIFPA, PANLAR, SOLAPSO, and COLAPPIEL. Read the full announcement: psoriasiscouncil.org/ipc-news/inter…

Delegates from 13 countries across Latin America participated in the 2026 IPC Psoriasis Masterclass over the past five weeks, with case-based education & discussion on psoriasis mgmt, comorbidities, PsA, GPP, & more. Thanks to Takeda for supporting this educational program.

Thank you to everyone who joined IPC #SID2026 for our symposium, The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure. Special thanks to our chairs, faculty, and Takeda for supporting this program. Stay tuned for recordings!

IPC and @CouncilEczema are partnering again for the 55th Annual ESDR Meeting this September in Heidelberg, Germany, to host the #Eczema and #Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum. Register today: psoriasiscouncil.org/event-post/esd… #DermatologyEvent

The IPC Symposium: The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure is today at 08:00 CDT at the Hilton Chicago, Room: Continental B, Lobby Level. Thanks to @TakedaPharma for supporting this program: psoriasiscouncil.org/event-post/sid…

The 2026 IPC Psoriasis Masterclass for Europe launched today, bringing together delegates from 24 countries for five weeks of case-based education and discussion on psoriasis across the disease spectrum. Thank you to Almirall and @TakedaPharma for supporting this Masterclass.

IPC, SOLAPSO, & SOARPSO are partnering during RADLA 2026 for a partnership symposium, Clinical Challenges in Psoriasis: When Severity, Timing, and Age Matter. Sessions will cover psoriasis severity and early intervention: psoriasiscouncil.org/event-post/rad… #RADLA2026 #Psoriasis #IPC

As the #IFPAForum Africa comes to a close, IPC would like to thank @PsoriasisIFPA, PsorAfrica, participating orgs, speakers, patient advocates, & attendees for an important week of collaboration and discussion in Nairobi. Thanks @TakedaPharma for supporting IPC at the IFPA Forum.

Headed to #SID2026? Join the IPC Symposium: The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure. Thank you to Takeda for supporting this program. View the agenda and register: psoriasiscouncil.org/event-post/sid… #Psoriasis #Dermatology

Revisit this resource from the IPC 2024 Global Webinar Series featuring #IPCCouncilor Cristina Echeverria, reviewing treatment approaches for psoriasis affecting the scalp, face, and genital region, along with ongoing studies and emerging therapies. psoriasiscouncil.org/resources/high…